Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Irving

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
RMD Open|September 30, 2020
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort studyJames Galloway, Kevin Barrett, Peter Irving, et al.
International Journal of Food Sciences and Nutrition|March 25, 2011
Fructan content of commonly consumed wheat, rye and gluten-free breadsKevin Whelan, Olivia Abrahmsohn, Gondi J P David, et al.
BMJ Open|January 24, 2025
Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE)Beverley Rodger, Jennifer Clough, Joana Vasconcelos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2017
Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel SyndromeMegan Rossi, Raphael Aggio, Heidi M Staudacher, et al.
Digestive Diseases (Basel, Switzerland)|September 4, 2017
Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of CorticosteroidsSadaf Asl Baakhtari, Andrew McCombie, Sebastiaan Ten Bokkel Huinink, et al.
The American Journal of Gastroenterology|July 18, 2023
P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 TrialJean-Frederic Colombel, Geert D'Haens, Peter Irving, et al.
Inflammatory Bowel Diseases|August 25, 2016
Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case SeriesTiong Yeng Lim, Polychronis Pavlidis, Shraddha Gulati, et al.
Therapeutic Advances in Gastroenterology|June 4, 2026
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomesKeith Bodger, Cheryl Booker, Frederick Taylor, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|July 29, 2020
Development and validation of metric-based-training to proficiency simulation curriculum for upper gastrointestinal endoscopy using a novel assessment checklistNahla Azzam, Nehal Khamis, Majid Almadi, et al.
Pharmacogenomics|July 17, 2009
Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugsLeslie J Sheffield, Peter Irving, Arun Gupta, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
RMD Open|September 30, 2020
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort studyJames Galloway, Kevin Barrett, Peter Irving, et al.
International Journal of Food Sciences and Nutrition|March 25, 2011
Fructan content of commonly consumed wheat, rye and gluten-free breadsKevin Whelan, Olivia Abrahmsohn, Gondi J P David, et al.
BMJ Open|January 24, 2025
Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE)Beverley Rodger, Jennifer Clough, Joana Vasconcelos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2017
Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel SyndromeMegan Rossi, Raphael Aggio, Heidi M Staudacher, et al.
Digestive Diseases (Basel, Switzerland)|September 4, 2017
Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of CorticosteroidsSadaf Asl Baakhtari, Andrew McCombie, Sebastiaan Ten Bokkel Huinink, et al.
The American Journal of Gastroenterology|July 18, 2023
P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 TrialJean-Frederic Colombel, Geert D'Haens, Peter Irving, et al.
Inflammatory Bowel Diseases|August 25, 2016
Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case SeriesTiong Yeng Lim, Polychronis Pavlidis, Shraddha Gulati, et al.
Therapeutic Advances in Gastroenterology|June 4, 2026
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomesKeith Bodger, Cheryl Booker, Frederick Taylor, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|July 29, 2020
Development and validation of metric-based-training to proficiency simulation curriculum for upper gastrointestinal endoscopy using a novel assessment checklistNahla Azzam, Nehal Khamis, Majid Almadi, et al.
Pharmacogenomics|July 17, 2009
Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugsLeslie J Sheffield, Peter Irving, Arun Gupta, et al.
Pageof 5